Beyond Clozapine Failure: Precision Approach and Palliative Psychiatry in Ultra-Treatment-Resistant Schizophrenia
Clozapine is the only evidence-based treatment for treatment-resistant schizophrenia (TRS); however, up to 70% of patients have an inadequate response, leading to clozapine-resistant schizophrenia (CRS) and, in its most severe form, ultra-treatment-resistant schizophrenia (UTRS). Because evidence-based treatment algori...